The Global Story: Will the new cancer vaccine survive RFK Jr’s America?
A promising mRNA-based personalized cancer vaccine has emerged as a major scientific breakthrough, yet its future in the U.S. is clouded by political controversy and funding cuts driven by vaccine skepticism, despite overwhelming scientific support for the technology's efficacy and safety
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Guest
Tom Whipple
narrative on Global News Podcast
Mentions
Books, people, and resources mentioned in this episode.
People
Companies
Research & Papers
Topics
Listen to This Episode
More from Global News Podcast
Artificial Intelligence used to create new viruses
Former Prince Andrew released as investigations continue
Shell accused of ignoring pollution evidence in Nigeria
Right-wing outsider wins Colombian election first round
Trump heads to China for crucial talks with Xi Jinping
The Happy Pod: All aboard the Bike Bus
Related episodes
From other shows on similar topics.
The Cancer Vaccine That Could Save Moderna
The Journal.
Longer Life: What Does Science Say?
On with Kara Swisher
How a single flu shot could protect you for decades
Short Wave
NPR News: 07-02-2026 7PM EDT
NPR News Now
$40,047,425,768,420 in U.S. Debt, and an Experimental Vaccine for Skin Cancer
The Headlines
Episode 208: Bad News, Good News
Osterholm Update
Get summaries like this every morning.
Free AI-powered recaps of Global News Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.